格隆匯個股放量排行榜 | 2月22日
格隆匯勾股大數據顯示，上一交易日維亞生物(01873)、浙江世寶(01057)、中國三江化工(02198)、寶新金融(01282)、福壽園(01448)、農夫山泉(09633)、延長石油國際(00346)、南方錳業(01091)、東吳水泥(00695)、澳博控股(00880)、中國先鋒醫藥(01345)、百融雲-W(06608)、德視佳(01846)、中達集團控股(00139)、新意網集團(01686)、華興資本控股(01911)、國藝集團控股(08228)、達力普控股(01921)、石四藥集團(02005)、上坤地產(06900)、康基醫療(09997)、翰森製藥(03692)、騰盛博藥-B(02137)、贏家時尚(03709)、辰林教育(01593)、康橋悦生活(02205)、英恆科技(01760)、銀河娛樂(00027)、銀城國際控股(01902)、中國天保集團(01427)、文化傳信(00343)、稀美資源(09936)、五菱汽車(00305)、順豐同城(09699)、綠城中國(03900)、德林控股(01709)、微博-SW(09898)、華誼騰訊娛樂(00419)、富匯國際集團控股(01034)、阜豐集團(00546)、中國中冶(01618)、天工國際(00826)、楓葉教育(01317)、玖源集團(00827)、永利澳門(01128)、ESR(01821)、國際永勝集團(08441)、長江生命科技(00775)、光正教育(06068)、科濟藥業-B(02171)、網龍(00777)、雍禾醫療(02279)、四環醫藥(00460)、培力農本方(01498)、興達國際(01899)、維達國際(03331)、融信服務(02207)、思考樂教育(01769)、三葉草生物-B(02197)、安能物流(09956)、昭衍新藥(06127)出現放量，量比分別為2.33、2.28、1.79、1.79、1.63、1.43、1.39、1.37、1.33、1.31、1.28、1.18、1.17、1.15、1.13、1.08、1.06、1.06、1.04、1.01、0.95、0.94、0.94、0.93、0.91、0.90、0.85、0.83、0.83、0.81、0.81、0.79、0.79、0.78、0.76、0.76、0.71、0.70、0.66、0.66、0.65、0.64、0.59、0.59、0.59、0.55、0.55、0.54、0.46、0.44、0.43、0.42、0.37、0.33、0.32、0.29、0.29、0.26、0.25、0.22、0.15。
備註：以上數據由格隆匯數據中心根據港交所數據加工計算所得，並不保證100%精確。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
